| Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform P Marcato, CA Dean, CA Giacomantonio, PWK Lee Cell cycle 10 (9), 1378-1384, 2011 | 630 | 2011 |
| Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis P Marcato, CA Dean, D Pan, R Araslanova, M Gillis, M Joshi, L Helyer, ... Stem cells 29 (1), 32-45, 2011 | 553 | 2011 |
| Assessment in mice of the therapeutic potential of tailored, multivalent Shiga toxin carbohydrate ligands GL Mulvey, P Marcato, PI Kitov, J Sadowska, DR Bundle, GD Armstrong The Journal of infectious diseases 187 (4), 640-649, 2003 | 197 | 2003 |
| Ras transformation mediates reovirus oncolysis by enhancing virus uncoating, particle infectivity, and apoptosis-dependent release P Marcato, M Shmulevitz, D Pan, D Stoltz, PWK Lee Molecular therapy 15 (8), 1522-1530, 2007 | 193 | 2007 |
| Reovirus virotherapy overrides tumor antigen presentation evasion and promotes protective antitumor immunity SA Gujar, P Marcato, D Pan, PWK Lee Molecular cancer therapeutics 9 (11), 2924-2933, 2010 | 133 | 2010 |
| Immunoprophylactic potential of cloned Shiga toxin 2 B subunit P Marcato, G Mulvey, RJ Read, K Vander Helm, PN Nation, GD Armstrong The Journal of infectious diseases 183 (3), 435-443, 2001 | 132 | 2001 |
| Aldehyde dehydrogenase 1A3 influences breast cancer progression via differential retinoic acid signaling P Marcato, CA Dean, RZ Liu, KM Coyle, M Bydoun, M Wallace, ... Molecular oncology 9 (1), 17-31, 2015 | 127 | 2015 |
| Unshackling the links between reovirus oncolysis, Ras signaling, translational control and cancer M Shmulevitz, P Marcato, PWK Lee Oncogene 24 (52), 7720-7728, 2005 | 123 | 2005 |
| The RAS/Raf1/MEK/ERK signaling pathway facilitates VSV-mediated oncolysis: implication for the defective interferon response in cancer cells JA Noser, AA Mael, R Sakuma, S Ohmine, P Marcato, PWK Lee, Y Ikeda Molecular Therapy 15 (8), 1531-1536, 2007 | 121 | 2007 |
| Oncolytic reovirus effectively targets breast cancer stem cells P Marcato, CA Dean, CA Giacomantonio, PWK Lee Molecular Therapy 17 (6), 972-979, 2009 | 105 | 2009 |
| Targeting cancer-initiating cells with oncolytic viruses TP Cripe, PY Wang, P Marcato, YY Mahller, PWK Lee Molecular Therapy 17 (10), 1677-1682, 2009 | 104 | 2009 |
| Hide-and-seek: the interplay between cancer stem cells and the immune system M Sultan, KM Coyle, D Vidovic, ML Thomas, S Gujar, P Marcato Carcinogenesis 38 (2), 107-118, 2017 | 102 | 2017 |
| Core needle biopsy of breast cancer tumors increases distant metastases in a mouse model EG Mathenge, CA Dean, D Clements, A Vaghar-Kashani, S Photopoulos, ... Neoplasia 16 (11), 950-960, 2014 | 101 | 2014 |
| LncRNA-miRNA axes in breast cancer: novel points of interaction for strategic attack J Venkatesh, MCD Wasson, JM Brown, W Fernando, P Marcato Cancer letters 509, 81-88, 2021 | 99 | 2021 |
| Citral reduces breast tumor growth by inhibiting the cancer stem cell marker ALDH1A3 ML Thomas, R De Antueno, KM Coyle, M Sultan, BM Cruickshank, ... Molecular oncology 10 (9), 1485-1496, 2016 | 93 | 2016 |
| ALDH1A3-regulated long non-coding RNA NRAD1 is a potential novel target for triple-negative breast tumors and cancer stem cells D Vidovic, TT Huynh, P Konda, C Dean, BM Cruickshank, M Sultan, ... Cell Death & Differentiation 27 (1), 363-378, 2020 | 91 | 2020 |
| A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations C Canino, YY Luo, P Marcato, G Blandino, HI Pass, M Cioce Oncotarget 6 (14), 12637, 2015 | 86 | 2015 |
| Oncolytic virus-initiated protective immunity against prostate cancer SA Gujar, DA Pan, P Marcato, KA Garant, PWK Lee Molecular Therapy 19 (4), 797-804, 2011 | 84 | 2011 |
| Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulation S Gujar, R Dielschneider, D Clements, E Helson, M Shmulevitz, ... Molecular Therapy 21 (2), 338-347, 2013 | 83 | 2013 |
| Glycan mimicry as a basis for novel anti-infective drugs G Mulvey, PI Kitov, P Marcato, DR Bundle, GD Armstrong Biochimie 83 (8), 841-847, 2001 | 80 | 2001 |
